synucleinopathy

Mohamed Bilal Fares1, Omar Alijevic1, Stephanie Johne1

  • 1PMI R&D, Philip Morris Products S.A., Neuchâtel, Switzerland.

Frontiers in neuroscience
|September 18, 2023
PubMed
概括

在帕金森病模型中,尼古丁治疗减少了α-synuclein (α-Syn) 聚合和神经毒性. 激活α4β2尼古丁受体似乎调解了这些神经保护作用,提供了潜在的治疗途径.